e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nsclc and egfr activating mutations (EGFRm+). Experience from a reference center in Greece.
S. Chrysikos (ATHENS, Greece)
Source:
International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session:
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session type:
Thematic Poster
Number:
4259
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chrysikos (ATHENS, Greece). Nsclc and egfr activating mutations (EGFRm+). Experience from a reference center in Greece.. 4259
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Description of new CFTR gene’s mutations in patients of Russia
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment – prospective data from the Czech TULUNG registry
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
Genetic and epigenetic analysis of the 17q12-21 locus in the Saguenay–Lac-Saint-Jean (SLSJ) asthma familial cohort.
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Comparison of NSCLC patient groups with activated EGFR mutations treated with three different tyrosine-kinase inhibitors (TKI): Real-life data from the Czech Republic
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Target other gene point mutations: HER2 and rare EGFR mutations
Source: ERS Research Seminar
Year: 2015
Tuberculosis incidence in Sardinia (Italy) in the adult population, in the last 8 years (2002-2009): Increase, decrease or stabilization? Preliminary data
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010
Frequency of α-1 antitrypsin deficiency (AATD) in a population screening in an high risk area (Val Trompia, Italy)
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006
Mannose-binding lectin promoter polymorphisms and gene variants in pulmonary tuberculosis patients from Cantabria (Northern Spain)
Source: Annual Congress 2013 –Tuberculosis susceptibility: genetic polymorphism and vitamin D deficiency
Year: 2013
The downstream effects of the 17q12-21 asthma region. Is functional splicing of GSDMB the explanation?
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Local clustering of lung carcinoid tumors (LCTs) in a small area of central Greece: genetic abnormalities involving multiple endocrine neoplasia 1 (MEN1) gene on chromosome 11q
Source: Eur Respir J 2005; 26: Suppl. 49, 91s
Year: 2005
The correlation between IRF-7 polymorphism (rs3758650) and tuberculosis in Chinese Han people
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from Poland
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Genetic analysis of the mouse bradypneic (
bd
) mutation
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Polymorphism in the length of CA repeat in intron 1 of EGFR of NSCLC in Japan
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Uncommon EGFR mutations of lung adenocarcinoma in one tertiary institution, Korea: clinical characteristics and treatment response to tyrosine kinase inhibitors
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
A review of in-house Video Observed Therapy (VOT) for patients with active tuberculosis(TB), in a London teaching hospital.
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
Topological data analysis (TDA) of U-BIOPRED paediatric peripheral blood gene expression identified asthma phenotypes characterised by alternative splicing of glucocorticoid receptor (GR) mRNA
Source: International Congress 2018 – New developments in paediatric asthma
Year: 2018
Utilization of FIXED combination (FC) in the treatment of asthma patients in real life condition in the Czech Republic (UFO)
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept